https://sputnikglobe.com/20211013/russia-approves-trials-of-sputnik-v-vaccine-in-form-of-nasal-spray-1089893499.html
Russia Approves Trials of Sputnik V Vaccine in Form of Nasal Spray
Russia Approves Trials of Sputnik V Vaccine in Form of Nasal Spray
Sputnik International
MOSCOW (Sputnik) - The Russian Ministry of Health has approved trials of a nasal spray form of the Sputnik V coronavirus vaccine, the state registry said on... 13.10.2021, Sputnik International
2021-10-13T14:00+0000
2021-10-13T14:00+0000
2021-10-13T14:00+0000
newsfeed
vaccine
covid-19
sputnik v vaccine
https://cdn1.img.sputnikglobe.com/img/07e5/05/09/1082841328_0:141:3141:1907_1920x0_80_0_0_5efa5e2271812813545254c55ab15e01.jpg
The trials, involving 500 volunteers, will end on December 31, 2023, the registry added.This form of the vaccine is more suitable for rolling out to large populations and has fewer side effects.The Gamaleya Research Centre is the developer of the world's first COVID-19 vaccine, Sputnik V. The shot has been authorised for use in 70 countries, with a total population of about 4 billion people. In terms of the number of approvals from government regulators, it ranks second in the world.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
newsfeed, vaccine, covid-19, sputnik v vaccine
newsfeed, vaccine, covid-19, sputnik v vaccine
Russia Approves Trials of Sputnik V Vaccine in Form of Nasal Spray
MOSCOW (Sputnik) - The Russian Ministry of Health has approved trials of a nasal spray form of the Sputnik V coronavirus vaccine, the state registry said on Wednesday.
The trials, involving 500 volunteers, will end on December 31, 2023, the registry added.
This form of the vaccine is more suitable for rolling out to large populations and has fewer side effects.
The Gamaleya Research Centre is the developer of the world's first COVID-19 vaccine, Sputnik V. The shot has been authorised for use in 70 countries, with a total population of about 4 billion people. In terms of the number of approvals from government regulators, it ranks second in the world.
